Post endoscopic retrograde cholangio-pancreaticography (ERCP) pancreatitis

Simple item page
dc.contributor.advisorYasser Abu Safieh
dc.contributor.authorYasmine, Hamdan
dc.date.accessioned2020-08-06T11:11:27Z
dc.date.available2020-08-06T11:11:27Z
dc.date.issued2013-05-20
dc.description.abstractAbstract: Introduction and aim: In several studies non-steroidal anti inflammatory drugs (NSAIDs) shown to reduce post endoscopic retrograde cholangio-pancreaticography (ERCP) pancreatitis incidence and severity. Our aim is to study the effect of NSAIDs in reducing both incidence and severity of post ERCP pancreatitis (PEP). Patients and methods: A double blind placebo controlled study was conducted on patients who had ERCP at Specialized Arab Hospital (SAH), collected over 5 months, from Nov to Mar 2012- 2013 . Patients were randomized by an endoscopy nurse to receive IM Diclofenac 75 mg, or IM isotonic saline 3 ml as placebo, 12 hours after completing the procedure. All patients were evaluated for abdominal pain and serum amylase. Results: The total number of patients was 121 patients, 11 patients were excluded,110 patients completed the study; Diclofenac group (56 patients) and placebo (54 patients).The two groups were comparable for the following: age, sex, ERCP finding, pancreatic duct cannulation, failure of common bile duct (CBD) cannulation, number of pancreatic duct cannulation, ERCP time, sphincterotomy, and stenting. The overall incidence of pancreatitis was 10% (11/110), 7% (4/56) for the diclofenac group and 13% (7/54) for the placebo group. There was no significant difference in the incidence of pancreatitis between the two groups; the P value was 0.31. In the subgroup analysis, the frequency of pancreatitis in the patients with pancreatic duct cannulation ≥3 times was significantly lower in the diclofenac group than in the control group (P value = 0.014) In all the cases in which pancreatitis occurs, it was mild or moderate; there was no severe pancreatitis among the two groups. Conclusion: Intramuscular diclofenac lowered PEP rate in the patients with repeated canulation of pancreatic duct which carried high risk of PEP.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.11888/15077
dc.language.isoenen_US
dc.subjectdiclofenac, ERCP and pancreatitisen_US
dc.titlePost endoscopic retrograde cholangio-pancreaticography (ERCP) pancreatitisen_US
dc.typeGraduation Projecten_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Post endoscopic retrograde cholangio-pancreaticography (ERCP) pancreatitis.pdf
Size:
67.14 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Doctor of Medicine